EF Hutton analyst Constantine Davides maintains Electromed (AMEX:ELMD) with a Buy and raises the price target from $13.5 to $15.
TransDigm Analysts Increase Their Forecasts Following Strong Earnings
TransDigm Group Incorporated (NYSE: TDG) reported better-than-expected fourth-quarter financial results on Thursday.